Maurizio Romano

Prof. Maurizio Romano

Department of Life Sciences, University of Trieste, 34127 Trieste, Italy
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2010 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
YAYouhna M Ayala
Youhna M Ayala
LCLaura De Conti
Laura De Conti
SAS. Eréndira Avendaño-Vázquez
S. Eréndira Avendaño-Vázquez
ADAshish Dhir
Ashish Dhir
Maurizio RomanoMaurizio Romano
Maurizio Romano
FBFrancisco E Baralle
Francisco E Baralle
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

2 April 2001 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
Emanuele BurattiEmanuele Buratti
Emanuele Buratti
TDThilo Dörk
Thilo Dörk
EZElisabetta Zuccato
Elisabetta Zuccato
FPFranco Pagani
Franco Pagani
Maurizio RomanoMaurizio Romano
Maurizio Romano
FBFrancisco E. Baralle
Francisco E. Baralle
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 May 2005 in Journal of Molecular Biology
Verified
Journal Article
Closed access
YAYouhna M. Ayala
Youhna M. Ayala
SPSergio Pantano
Sergio Pantano
ADAndrea D'Ambrogio
Andrea D'Ambrogio
Emanuele BurattiEmanuele Buratti
Emanuele Buratti
ABAntonia Brindisi
Antonia Brindisi
FBFrancisco E. Baralle
Francisco E. Baralle

8 May 2009 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ADAndrea D’ambrogio
Andrea D’ambrogio
Emanuele BurattiEmanuele Buratti
Emanuele Buratti
CSCristiana Stuani
Cristiana Stuani
CGCorrado Guarnaccia
Corrado Guarnaccia
Maurizio RomanoMaurizio Romano
Maurizio Romano
FBFrancisco E. Baralle
Francisco E. Baralle
Nuclear factor TDP-43 has been reported to play multiple roles in transcription, pre-mRNA splicing, mRNA stability and mRNA transport. From a structural point of view, TDP-43 is a member of the hnRNP protein family whose structure includes two RRM domains flanked by the N-terminus and C-terminal regions. Like many members of this family, the C-terminal region can interact with cellular factors and thus serve to modulate its function. Previously, we have described that TDP-43 binds to several members of the hnRNP A/B family through this region. In this work, we set up a coupled minigene/siRNA cellular system that allows us to obtain in vivo data to address the functional significance of TDP-43-recruited hnRNP complex formation. Using this method, we have finely mapped the interaction between TDP-43 and the hnRNP A2 protein to the region comprised between amino acid residues 321 and 366. Our results provide novel details of protein–protein interactions in splicing regulation. In addition, we provide further insight on TDP-43 functional properties, particularly the lack of effects, as seen with our assays, of the disease-associated mutations that fall within the TDP-43 321-366 region: Q331K, M337V and G348C.

26 April 2010 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
Emanuele BurattiEmanuele Buratti
Emanuele Buratti
LCLaura De Conti
Laura De Conti
CSCristiana Stuani
Cristiana Stuani
Maurizio RomanoMaurizio Romano
Maurizio Romano
Marco BaralleMarco Baralle
Marco Baralle
FBFrancisco Baralle
Francisco Baralle
TDP‐43 has recently been described as the major component of the inclusions found in the brain of patients with a variety of neurodegenerative diseases, such as frontotemporal lobar degeneration and amyotrophic lateral sclerosis. TDP‐43 is a ubiquitous protein whose specific functions are probably crucial to establishing its pathogenic role. Apart from its involvement in transcription, splicing and mRNA stability, TDP‐43 has also been described as a Drosha‐associated protein. However, our knowledge of the role of TDP‐43 in the microRNA (miRNA) synthesis pathway is limited to the association mentioned above. Here we report for the first time which changes occur in the total miRNA population following TDP‐43 knockdown in culture cells. In particular, we have observed that let‐7b and miR‐663 expression levels are down‐ and upregulated, respectively. Interestingly, both miRNAs are capable of binding directly to TDP‐43 in different positions: within the miRNA sequence itself (let‐7b) or in the hairpin precursor (miR‐663). Using microarray data and real‐time PCR we have also identified several candidate transcripts whose expression levels are selectively affected by these TDP‐43–miRNA interactions.

18 June 2007 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
Emanuele BurattiEmanuele Buratti
Emanuele Buratti
MCMartin Chivers
Martin Chivers
JKJana Královičová
Jana Královičová
Maurizio RomanoMaurizio Romano
Maurizio Romano
Marco BaralleMarco Baralle
Marco Baralle
IVIgor Vořechovský
Igor Vořechovský
Despite a growing number of splicing mutations found in hereditary diseases, utilization of aberrant splice sites and their effects on gene expression remain challenging to predict. We compiled sequences of 346 aberrant 5′splice sites (5′ss) that were activated by mutations in 166 human disease genes. Mutations within the 5′ss consensus accounted for 254 cryptic 5′ss and mutations elsewhere activated 92 de novo 5′ss. Point mutations leading to cryptic 5′ss activation were most common in the first intron nucleotide, followed by the fifth nucleotide. Substitutions at position +5 were exclusively G>A transitions, which was largely attributable to high mutability rates of C/G>T/A. However, the frequency of point mutations at position +5 was significantly higher than that observed in the Human Gene Mutation Database, suggesting that alterations of this position are particularly prone to aberrant splicing, possibly due to a requirement for sequential interactions with U1 and U6 snRNAs. Cryptic 5′ss were best predicted by computational algorithms that accommodate nucleotide dependencies and not by weight-matrix models. Discrimination of intronic 5′ss from their authentic counterparts was less effective than for exonic sites, as the former were intrinsically stronger than the latter. Computational prediction of exonic de novo 5′ss was poor, suggesting that their activation critically depends on exonic splicing enhancers or silencers. The authentic counterparts of aberrant 5′ss were significantly weaker than the average human 5′ss. The development of an online database of aberrant 5′ss will be useful for studying basic mechanisms of splice-site selection, identifying splicing mutations and optimizing splice-site prediction algorithms.